Listen for Questions About Leqembi for Alzheimer’s Disease
April 2023
You’ll hear buzz about Leqembi (lecanemab), a new med for Alzheimer’s disease.
It joins Aduhelm (aducanumab) as the second IV monoclonal antibody to treat mild Alzheimer’s. Neither is for more severe disease.
Like Aduhelm, Leqembi is touted to affect the underlying disease...by decreasing “amyloid plaque” in the brain.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote